Search research articles
Contact Us
Filters
Showing results (181-190 of 258) with videos related to
Page
of 26
Sort By:
Arthritis and Rheumatism
|
August 6, 2005
Spondyloarthritis Research Consortium of Canada magnetic resonance imaging index for assessment of spinal inflammation in ankylosing spondylitis
Walter P Maksymowych, Robert D Inman, David Salonen, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
August 20, 2024
Enhanced Type 1 Interferon Signature in Axial Spondyloarthritis Patients Unresponsive to Secukinumab Treatment
Addison Pacheco, Sinead Maguire, Zoya Qaiyum, et al.
Arthritis and Rheumatism
|
October 7, 2005
Spondyloarthritis research Consortium of Canada magnetic resonance imaging index for assessment of sacroiliac joint inflammation in ankylosing spondylitis
Walter P Maksymowych, Robert D Inman, David Salonen, et al.
Arthritis and Rheumatism
|
July 3, 2013
The impact of tumor necrosis factor α inhibitors on radiographic progression in ankylosing spondylitis
Nigil Haroon, Robert D Inman, Thomas J Learch, et al.
Arthritis Care & Research
|
July 16, 2021
Bridging the Gap Between Symptom Onset and Diagnosis in Axial Spondyloarthritis
Laura Passalent, Kala Sundararajan, Anthony V Perruccio, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 22, 2002
Modulation of Mac-1 (CD11b/CD18)-mediated adhesion by the leukocyte-specific protein 1 is key to its role in neutrophil polarization and chemotaxis
Chunjie Wang, Hisayoshi Hayashi, Rene Harrison, et al.
Vaccine
|
August 1, 2009
Vaccination of children in low-resource countries against Shigella is unlikely to present an undue risk of reactive arthritis
J S Hill Gaston, Robert D Inman, Edward T Ryan, et al.
Annals of the Rheumatic Diseases
|
February 20, 2014
Sarilumab for the treatment of ankylosing spondylitis: results of a Phase II, randomised, double-blind, placebo-controlled study (ALIGN)
Joachim Sieper, Jürgen Braun, Jonathan Kay, et al.
Annals of the Rheumatic Diseases
|
February 7, 2025
Impact of clinical subtype and sex on first-line biologic therapy discontinuation in axial spondyloarthritis
Patricia Remalante-Rayco, Emmanuel S Baja, Zeynep Baskurt, et al.
Annals of the Rheumatic Diseases
|
August 2, 2023
Proteomic and genomic profiling of plasma exosomes from patients with ankylosing spondylitis
Fataneh Tavasolian, Starlee Lively, Chiara Pastrello, et al.
Page
of 26
Search research articles
Search
Showing results (181-190 of 258) with videos related to
Sort By:
Page
of 26
Arthritis and Rheumatism
|
August 6, 2005
Spondyloarthritis Research Consortium of Canada magnetic resonance imaging index for assessment of spinal inflammation in ankylosing spondylitis
Walter P Maksymowych, Robert D Inman, David Salonen, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
August 20, 2024
Enhanced Type 1 Interferon Signature in Axial Spondyloarthritis Patients Unresponsive to Secukinumab Treatment
Addison Pacheco, Sinead Maguire, Zoya Qaiyum, et al.
Arthritis and Rheumatism
|
October 7, 2005
Spondyloarthritis research Consortium of Canada magnetic resonance imaging index for assessment of sacroiliac joint inflammation in ankylosing spondylitis
Walter P Maksymowych, Robert D Inman, David Salonen, et al.
Arthritis and Rheumatism
|
July 3, 2013
The impact of tumor necrosis factor α inhibitors on radiographic progression in ankylosing spondylitis
Nigil Haroon, Robert D Inman, Thomas J Learch, et al.
Arthritis Care & Research
|
July 16, 2021
Bridging the Gap Between Symptom Onset and Diagnosis in Axial Spondyloarthritis
Laura Passalent, Kala Sundararajan, Anthony V Perruccio, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 22, 2002
Modulation of Mac-1 (CD11b/CD18)-mediated adhesion by the leukocyte-specific protein 1 is key to its role in neutrophil polarization and chemotaxis
Chunjie Wang, Hisayoshi Hayashi, Rene Harrison, et al.
Vaccine
|
August 1, 2009
Vaccination of children in low-resource countries against Shigella is unlikely to present an undue risk of reactive arthritis
J S Hill Gaston, Robert D Inman, Edward T Ryan, et al.
Annals of the Rheumatic Diseases
|
February 20, 2014
Sarilumab for the treatment of ankylosing spondylitis: results of a Phase II, randomised, double-blind, placebo-controlled study (ALIGN)
Joachim Sieper, Jürgen Braun, Jonathan Kay, et al.
Annals of the Rheumatic Diseases
|
February 7, 2025
Impact of clinical subtype and sex on first-line biologic therapy discontinuation in axial spondyloarthritis
Patricia Remalante-Rayco, Emmanuel S Baja, Zeynep Baskurt, et al.
Annals of the Rheumatic Diseases
|
August 2, 2023
Proteomic and genomic profiling of plasma exosomes from patients with ankylosing spondylitis
Fataneh Tavasolian, Starlee Lively, Chiara Pastrello, et al.
Page
of 26